Escape Bio

Developer of therapeutic solutions for treating genetic neurodegenerative diseases

placeSan Francisco, California, United States calendar_todayFounded 2015 groups39 employees language escapebio.com

Innovation

6 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 374 times.

YearFilings
20214
20225
20234

Investor mix

15 investors on record; lead investors include Wellington, CAM Capital, New Leaf Venture Partners, Rock Springs Capital.

Investor typeCountShare
Venture capital747%
Other / undisclosed853%
Coming soon